DSY:EURONEXT PARISDassault Systemes SE Analysis
Data as of 2026-03-11 - not real-time
$3.01
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $3.01, well below its 20‑day ($3.60), 50‑day ($4.75) and 200‑day ($16.27) simple moving averages, underscoring a pronounced bearish trend. RSI sits at 32, flirting with oversold territory, while the MACD histogram has turned positive, hinting at a tentative bullish reversal. Volume is on an increasing trajectory, and the price hovers just above the identified support level of $2.80, suggesting a potential bounce but also limited downside cushion.
Recent corporate actions – a announced 1‑for‑20 reverse stock split and a shift to a dual‑class share structure – add short‑term uncertainty and could temporarily distort liquidity. The DCF‑derived fair value of $5.59 is markedly higher than the current price, implying undervaluation, yet the company’s fundamentals are weak: revenue fell 17%, operating margins are negative, cash flow is negative, and equity is negative with a book‑value per share of –$1.60. High 30‑day volatility (107%) and a historic max drawdown of –94% further amplify risk.
Recent corporate actions – a announced 1‑for‑20 reverse stock split and a shift to a dual‑class share structure – add short‑term uncertainty and could temporarily distort liquidity. The DCF‑derived fair value of $5.59 is markedly higher than the current price, implying undervaluation, yet the company’s fundamentals are weak: revenue fell 17%, operating margins are negative, cash flow is negative, and equity is negative with a book‑value per share of –$1.60. High 30‑day volatility (107%) and a historic max drawdown of –94% further amplify risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price well below all major moving averages
- Bearish overall trend despite MACD hint
- Potential volatility from upcoming reverse split
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Undervaluation relative to DCF fair value
- Increasing volume suggesting accumulating interest
- Uncertainty around dual‑class share structure
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Negative operating cash flow and declining revenue
- Negative book value and high debt levels
- Sustained high volatility and historic drawdown
Key Metrics & Analysis
Financial Health
Revenue Growth-17.30%
Profit Margin8.75%
ROA-0.16%
P/B Ratio-1.9
Op. Cash Flow$-1513072
Free Cash Flow$2.0M
Technical Analysis
TrendBearish
RSI32.0
Support$2.80
Resistance$5.00
MA 20$3.60
MA 50$4.75
MA 200$16.27
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value$5.59
GradeUndervalued
TypeValue
Risk Assessment
Beta1.04
Volatility107.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.